Word

CG PHARMACEUTICALS

Status

Pending

Status Code

730

Status Date

Tuesday, April 2, 2024

Serial Number

97270460

Mark Type

5000

Filing Date

Wednesday, February 16, 2022

Published for Opposition

Tuesday, August 8, 2023

Trademark Owner History

CG Pharmaceuticals, Inc - Owner At Publication

Classifications

41 Educational services, namely, conducting seminars regarding the use of prescription pharmaceutical products for medical disorders and dissemination of materials in connection therewith; providing motivational and educational speakers featuring information regarding medical disorders; conducting educational seminars in the field of medicine, medical disorders, cancer treatment and diagnosis, biologics, and pharmaceutical products and dissemination of materials in connection therewith; educational services, namely, conducting classes, seminars, conferences or workshops in the field of medicine, medical disorders, cancer treatment and diagnosis, biologics, and pharmaceutical products

5 biopharmaceutical preparations for the treatment of cancer; biopharmaceutical preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; biologic preparations for the treatment of cancer; biologic preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of chronic diseases, namely, dementia, Alzheimer's disease, arthritis, rheumatoid arthritis, fibrosis, pulmonary fibrosis, idiopathic pulmonary fibrosis, kidney disease, inflammatory bowel disease, gastrointestinal disease, infectious diseases, neurodegenerative diseases, immunological disorders, and inflammatory diseases; pharmaceutical preparations and substances for use in oncology treatment; pharmaceuticals for the treatment of cancer; prescription pharmaceuticals for treatment of diseases and disorders, namely, cancer and chronic diseases

44 Providing health and medical information about medical disorders and their diagnosis, prevention and treatment; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, including pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services; information and advisory services relating to pharmaceuticals, diseases and medical conditions and treatments, including pharmaceutical advice, medical and pharmaceutical consultation, medical advisory services, and providing medical information, consultancy and advisory services provided on-line over a computer network and the Internet; Providing information regarding medical conditions; medical information services; providing medical information regarding testing, diagnosis, and treatment of diseases; providing medical information to patients regarding disease management and medication

42 Medical and scientific research, including conducting clinical trials for others, in the field of cancer treatment and diagnosis; scientific research in the nature of conducting clinical trials for others; basic and clinical research in the field of respiratory science and medicine; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical and scientific research in the field of cancer treatment and diagnosis; providing information about medical research in the field of cancer; providing information about medical research in the field of vaccines; providing information about medical research in the field of medical diagnostic instruments; research in the field of biologics; providing information about medical research in the field of biologics; scientific research for medical purposes in the area of cancerous diseases; pharmaceutical research and development; research and development in the pharmaceutical and biotechnology fields

The mark consists of the term CG PHARMACEUTICALS in a stylized format.
Color is not claimed as a feature of the mark.
"PHARMACEUTICALS"

Trademark Events

Apr 3, 2024

Notice Of Approval Of Extension Request E-Mailed

Apr 2, 2024

Sou Extension 1 Granted

Apr 2, 2024

Sou Extension 1 Filed

Apr 2, 2024

Sou Teas Extension Received

Oct 3, 2023

Noa E-Mailed - Sou Required From Applicant

Aug 8, 2023

Official Gazette Publication Confirmation E-Mailed

Aug 8, 2023

Published For Opposition

Jul 19, 2023

Notification Of Notice Of Publication E-Mailed

Jul 2, 2023

Approved For Pub - Principal Register

Jun 2, 2023

Teas/Email Correspondence Entered

Jun 1, 2023

Correspondence Received In Law Office

Jun 1, 2023

Teas Response To Office Action Received

Dec 1, 2022

Notification Of Non-Final Action E-Mailed

Dec 1, 2022

Non-Final Action E-Mailed

Dec 1, 2022

Non-Final Action Written

Nov 30, 2022

Assigned To Examiner

Feb 22, 2022

New Application Office Supplied Data Entered

Feb 19, 2022

New Application Entered